Reform of NICE needed to boost its credibilityBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7325.1324/a (Published 08 December 2001) Cite this as: BMJ 2001;323:1324
- Zosia Kmietowicz
The National Institute for Clinical Excellence risks losing further public confidence unless it becomes more explicit and open about how it arrives at decisions on whether drugs should be funded by the health service, the Consumers' Association has said.
An inquiry carried out by the Consumers'Association found that many patient groups, some of which spend as much as £40000 ($56000) preparing their evidence for a drug appraisal, are frustrated …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial